| pubmed-article:19042161 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19042161 | lifeskim:mentions | umls-concept:C0002395 | lld:lifeskim |
| pubmed-article:19042161 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:19042161 | lifeskim:mentions | umls-concept:C0016967 | lld:lifeskim |
| pubmed-article:19042161 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:19042161 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:19042161 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19042161 | lifeskim:mentions | umls-concept:C0939465 | lld:lifeskim |
| pubmed-article:19042161 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19042161 | pubmed:dateCreated | 2008-12-16 | lld:pubmed |
| pubmed-article:19042161 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19042161 | pubmed:abstractText | The efficacy of galantamine has been shown in patients with mild, moderate, and advanced moderate Alzheimer's disease (AD). Here we report its efficacy in patients with severe AD. | lld:pubmed |
| pubmed-article:19042161 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19042161 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19042161 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19042161 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19042161 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19042161 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19042161 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19042161 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19042161 | pubmed:issn | 1474-4422 | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:BurnsAlistair... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:BullockRogerR | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:FrölichLutzL | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:HockChristoph... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:BernabeiRober... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:WimoAndersA | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:SchwalenSusan... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:RaivioMinnaM | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:VandewoudeMau... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:Cruz... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:TriauEricE | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:CameElizabeth... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:HammondGerry... | lld:pubmed |
| pubmed-article:19042161 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:19042161 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19042161 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:19042161 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19042161 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19042161 | pubmed:pagination | 39-47 | lld:pubmed |
| pubmed-article:19042161 | pubmed:dateRevised | 2009-2-11 | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:meshHeading | pubmed-meshheading:19042161... | lld:pubmed |
| pubmed-article:19042161 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19042161 | pubmed:articleTitle | Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. | lld:pubmed |
| pubmed-article:19042161 | pubmed:affiliation | University of Manchester, Manchester, UK. alistair.burns@manchester.ac.uk | lld:pubmed |
| pubmed-article:19042161 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19042161 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19042161 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19042161 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19042161 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19042161 | lld:pubmed |
